Forcefield Therapeutics
PrivateLast Round
Series A
Jun 20, 2024
Total Funding Raised
$82.9M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Forcefield Therapeutics is a biotechnology company that develops therapeutics to protect heart function by arresting the loss of cardiomyocytes following myocardial infarction.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Data as a Service, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Forcefield Therapeutics Comparables
Compare Forcefield Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Infensa Bioscience | 84% | |
| SERCA Pharmaceuticals | 80% | |
| Heqet Therapeutics | 78% |
Forcefield Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jun 20, 2024 | ||||
| Series A | Mar 28, 2024 | ||||
| Seed | Apr 25, 2022 |
Forcefield Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Roche Venture Fund | Series A |
| Syncona | Series A, Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 16, 2026
Monthly visitors grew 68% MoM.
- Jun 20, 2024
$38.1M round led by Syncona.
Forcefield Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Forcefield Therapeutics's valuation, stock price, and market status.
Is Forcefield Therapeutics a public or private company?
Forcefield Therapeutics is a private company.
What is the current stock price of Forcefield Therapeutics?
Forcefield Therapeutics is a private company with no public stock price. No recent secondary market data is available.
How much is Forcefield Therapeutics worth (valuation)?
Valuation information for Forcefield Therapeutics is not publicly available.
Can I buy Forcefield Therapeutics stock?
Forcefield Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Forcefield Therapeutics's last funding round?
Forcefield Therapeutics's most recent funding round was Seed on April 25, 2022.
Who are the main investors in Forcefield Therapeutics?
Key investors in Forcefield Therapeutics include Syncona.
Will Forcefield Therapeutics IPO soon?
No public IPO plans have been announced for Forcefield Therapeutics.
How can I track Forcefield Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Forcefield Therapeutics's secondary market activity and sign up for updates.